Page 29«..1020..28293031..4050..»

Category Archives: Ulcerative Colitis

Arena Pharmaceuticals’ Presence at the European Crohn’s and Colitis Organisation (ECCO) Congress Further Highlights Commitment to the GI Community -…

Posted: Published on February 11th, 2020

- New biomarker data from the open-label extension (OLE) of the Phase 2 OASIS trial for etrasimod in patients with moderately to severely active ulcerative colitis (UC) - Arena sponsored dinner symposium: HYPE, HOPE or REALITY? Integrating histology into a treat-to-target strategy in UC, with Chair: Professor William J Continue reading

Posted in Ulcerative Colitis | Comments Off on Arena Pharmaceuticals’ Presence at the European Crohn’s and Colitis Organisation (ECCO) Congress Further Highlights Commitment to the GI Community -…

Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2020 Financial Results and Recent Business Highlights – BioSpace

Posted: Published on February 11th, 2020

CRANBURY, N.J., Feb. 11, 2020 /PRNewswire/ --Palatin Technologies Inc. Continue reading

Posted in Ulcerative Colitis | Comments Off on Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2020 Financial Results and Recent Business Highlights – BioSpace

The Brave New World of Microbiome-based Therapies – BioSpace

Posted: Published on February 11th, 2020

The microbiome is the trillions of microorganismsbacteria, fungi, and virusesthat live in and on the body. Although it makes complete sense that these would play a factor in gastrointestinal diseases, such as Crohns and colitis, its less obvious that it would play a role in anything ranging from lung diseases to neurodegenerative diseases. But increasingly, evidence is suggesting it is, and a lot of investors are throwing money into the field in hopes it will come up with the next big blockbuster Continue reading

Posted in Ulcerative Colitis | Comments Off on The Brave New World of Microbiome-based Therapies – BioSpace

Protagonist Therapeutics to Present Preclinical Results on PN-943 at the 15th Congress of European Crohn’s and Colitis Organization (ECCO) – BioSpace

Posted: Published on February 11th, 2020

NEWARK, Calif., Feb. 7, 2020 /PRNewswire/ -- Protagonist Therapeutics, Inc., Inc. (Nasdaq:PTGX) today announced that the Company will present preclinical data on PN-943, the Company's oral, gut-restricted, alpha-4-beta-7 inhibitor candidate therapeutic, at the 15th Congress of the European Crohn's and Colitis Organization (ECCO), which will take place Feb. Continue reading

Posted in Ulcerative Colitis | Comments Off on Protagonist Therapeutics to Present Preclinical Results on PN-943 at the 15th Congress of European Crohn’s and Colitis Organization (ECCO) – BioSpace

What It Feels Like When You And Your 2-Year-Old Both Have To Wear Diapers – HuffPost

Posted: Published on February 11th, 2020

Diaper! my 2-year-old daughter says, pointing at my pink Depends. Thats right, honey, I say, forcing a smile, Mommy wears a diaper sometimes. Continue reading

Posted in Ulcerative Colitis | Comments Off on What It Feels Like When You And Your 2-Year-Old Both Have To Wear Diapers – HuffPost

Atlantic Healthcare Hosts Key Opinion Leader Discussion on Unmet Medical Need in Ulcerative Colitis and the Advantages of Alicaforsen – Yahoo Finance

Posted: Published on February 2nd, 2020

CAMBRIDGE, United Kingdom, Jan. 31, 2020 (GLOBE NEWSWIRE) -- Atlantic Healthcare plc (Atlantic Healthcare or Company), a specialist pharmaceutical company focused on acquiring, developing and commercializing therapeutics that address unmet patient needs and rare diseases, with a focus on gastroenterology hosted a Key Opinion Leader (KOL) event on the current treatment landscape and unmet medical need in Ulcerative Colitis (UC). Continue reading

Posted in Ulcerative Colitis | Comments Off on Atlantic Healthcare Hosts Key Opinion Leader Discussion on Unmet Medical Need in Ulcerative Colitis and the Advantages of Alicaforsen – Yahoo Finance

Pentasa (Ulcerative Colitis) Market Expert Guide to Boost the Industry in Global Market Share – Jewish Life News

Posted: Published on February 2nd, 2020

Global Pentasa (Ulcerative Colitis) Market 2019 by key players, regions, type, and application, forecast to 2025. Pentasa (Ulcerative Colitis) Market Report contains a forecast of 2019 and ending 2025 with a host of metrics like supply-demand ratio, Pentasa (Ulcerative Colitis) Market frequency, dominant players of Pentasa (Ulcerative Colitis) Market, driving factors, restraints, and challenges Continue reading

Posted in Ulcerative Colitis | Comments Off on Pentasa (Ulcerative Colitis) Market Expert Guide to Boost the Industry in Global Market Share – Jewish Life News

In a Mixed Quarter, Johnson & Johnson Shows Off Its Greatest Strength – The Motley Fool

Posted: Published on February 2nd, 2020

Johnson & Johnson (NYSE:JNJ) is the largest healthcare company in the world, but that hasn't stopped the pharma giant from encountering headwinds. It is currently involved in a slew of legal challenges, including lawsuits by consumers claiming that the company's talcum powder (which allegedly contained asbestos) caused their cancer Continue reading

Posted in Ulcerative Colitis | Comments Off on In a Mixed Quarter, Johnson & Johnson Shows Off Its Greatest Strength – The Motley Fool

Health Pro: Preventative aspect of field fascinated gastroenterologist – Florida Today

Posted: Published on February 2nd, 2020

FLORIDA TODAY Published 6:27 a.m. ET Jan. 28, 2020 Dr. Continue reading

Posted in Ulcerative Colitis | Comments Off on Health Pro: Preventative aspect of field fascinated gastroenterologist – Florida Today

AbbVie and Allergan Announce Agreements to Divest Brazikumab and Zenpep – PRNewswire

Posted: Published on February 2nd, 2020

NORTH CHICAGO, Ill. Continue reading

Posted in Ulcerative Colitis | Comments Off on AbbVie and Allergan Announce Agreements to Divest Brazikumab and Zenpep – PRNewswire

Page 29«..1020..28293031..4050..»